Cargando…

TSH ≥30 mU/L may not be necessary for successful (131)I remnant ablation in patients with differentiated thyroid cancer

PURPOSE: To determine whether thyroid-stimulating hormone level ≥ 30 mU/L is necessary for radioiodine ((131)I) remnant ablation (RRA) in patients with differentiated thyroid cancer (DTC), as well as its influencing factors and predictors. METHODS: A total of 487 DTC patients were retrospectively en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ju, Nianting, Hou, Liying, Song, Hongjun, Qiu, Zhongling, Wang, Yang, Sun, Zhenkui, Luo, Quanyong, Shen, Chentian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305696/ https://www.ncbi.nlm.nih.gov/pubmed/37022724 http://dx.doi.org/10.1530/ETJ-22-0219

Ejemplares similares

HIF-1α/YAP Signaling Rewrites Glucose/Iodine Metabolism Program to Promote Papillary Thyroid Cancer Progression
por: Song, Hongjun, et al.
Publicado: (2023)

Predicting (18)F-FDG SUVs of metastatic pulmonary nodes from CT images in patients with differentiated thyroid cancer by using a convolutional neural network
por: Ju, Nianting, et al.
Publicado: (2023)

Preablation Stimulated Thyroglobulin/TSH Ratio as a Predictor of Successful I(131)Remnant Ablation in Patients with Differentiated Thyroid Cancer following Total Thyroidectomy
por: Zubair Hussain, Syed, et al.
Publicado: (2014)

Recombinant TSH Stimulated Remnant Ablation Therapy in Thyroid Cancer: The Success Rate Depends on the Definition of Ablation Success—An Observational Study
por: van der Horst-Schrivers, Anouk N. A., et al.
Publicado: (2015)

I-131 remnant ablation after thyroidectomy induced hepatotoxicity in a case of thyroid cancer
por: Lin, Rong, et al.
Publicado: (2015)

SAT467 Monitoring TSH Over Time May Not Be Necessary in Patients With Thyroid Nodules
por: Kaul, Sabrina, et al.
Publicado: (2023)

Is routine measurement of TSH in hospitalized patients necessary?
por: Bashkin, Amir, et al.
Publicado: (2018)

Differential Diagnosis of Rare Diseases Involving Bilateral Lower Extremities with Similar (99m)Tc-MDP Bone Scan Patterns: Analysis of a Case Series
por: Sun, Zhenkui, et al.
Publicado: (2022)

The upper limit for TSH during pregnancy: why we should stop using fixed limits of 2.5 or 3.0 mU/l
por: Korevaar, Tim I. M.
Publicado: (2018)

Efficacy and Affecting Factors of (131)I Thyroid Remnant Ablation After Surgical Treatment of Differentiated Thyroid Carcinoma
por: Wang, Chen, et al.
Publicado: (2018)

Agenda for the 131st Meeting on 29 and 30 May 1990
por: CERN. Geneva. SPS Experiments Committee
Publicado: (1990)

Recombinant human TSH stimulated thyroglobulin levels at remnant ablation predict structural incomplete response to treatment in patients with differentiated thyroid cancer
por: Ha, Jeonghoon, et al.
Publicado: (2017)

I-131 for Remnant Ablation in Differentiated Thyroid Cancer After Thyroidectomy: A Meta-Analysis of Randomized Controlled Evidence
por: Shengguang, Yan, et al.
Publicado: (2016)

A case of the accumulation of 131-iodine in the mammary gland after remnant ablation for papillary thyroid carcinoma on lactating period
por: Murayama, Daisuke, et al.
Publicado: (2021)

Decisions taken at the 131st Meeting on 29 and 30 May 1990
por: CERN. Geneva. SPS Experiments Committee
Publicado: (1990)

The Influences of TSH Stimulation Level, Stimulated Tg Level and Tg/TSH Ratio on the Therapeutic Effect of (131)I Treatment in DTC Patients
por: Zheng, Wei, et al.
Publicado: (2021)

Radiation Safety and External Radiation Exposure Rate of Patients Receiving I-131 Therapy for Hyperthyroidism and Remnant Ablation as Outpatient: An Institutional Experience
por: Bhatia, Nisha, et al.
Publicado: (2023)

Inguinal draining-lymph node in (18)F-FDG PET/CT images could be a new indicator for the diagnosis of fracture-related infection in the lower extremities
por: Wang, Yanbing, et al.
Publicado: (2023)

Does the use of recombinant TSH in preparation for I-131 scintigraphy scan affect hearing function?
por: Doğan, Mehtap, et al.
Publicado: (2018)

Initial evaluation of thyroid dysfunction - Are simultaneous TSH and fT4 tests necessary?
por: Schneider, Claudio, et al.
Publicado: (2018)

Mu u.
por: Smiley, Jane
Publicado: (1995)

Is (131)I ablation necessary for patients with low-risk papillary thyroid carcinoma and slightly elevated stimulated thyroglobulin after thyroidectomy?
por: Rosario, Pedro Weslley, et al.
Publicado: (2016)

Strong Neck Accumulation of (131)I Is a Predictor of Incomplete Low-Dose Radioiodine Remnant Ablation Using Recombinant Human Thyroid-Stimulating Hormone
por: Enomoto, Keisuke, et al.
Publicado: (2015)

Radioiodine Remnant Ablation: A Critical Review
por: Bal, Chandra Sekhar, et al.
Publicado: (2015)

Activity of ceftolozane-tazobactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status
por: Johnston, Brian D., et al.
Publicado: (2018)

Activity of Ceftolozane-Tazobactam (C/T) against Escherichia coli Isolates from U.S. Veterans in Relation to Co-resistance and Sequence Type 131 (ST131) H30/H30Rx Status
por: Johnston, Brian D, et al.
Publicado: (2017)

Rate of thyroglossal duct remnant visualization after total thyroidectomy for differentiated thyroid carcinoma and its impact on clinical outcome of radioactive iodine (I-131) ablation
por: Mohamed Sayed, Mohamed Hosny, et al.
Publicado: (2015)

Diagnosis and Treatment of Acute Pleural Effusion following Radioiodine Remnant Ablation Post Lobectomy for Thyroid Cancer
por: Qiu, Xian, et al.
Publicado: (2022)

Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with (131)I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant Ablation
por: Signore, Alberto, et al.
Publicado: (2022)

SAT510 I-131 Therapy with Dosimetry for Advanced Thyroid Carcinoma: Recombinant TSH vs Thyroid Hormone Withdrawal
por: Awad, Dana, et al.
Publicado: (2023)

Individualized Selection Criteria Based on Tumor Burden in Future Remnant Liver for Staged Hepatectomy of Advanced CRLM: Conventional TSH or ALPPS
por: Chan, Kun-Ming, et al.
Publicado: (2022)

Effects of bone marrow cell transplant on thyroid function in an I(131)-induced low T4 and elevated TSH rat model
por: Guajardo-Salinas, Gustavo E, et al.
Publicado: (2007)

The clinical significance of remnant thyroid tissue in thyroidectomized differentiated thyroid cancer patients on (131)I-SPECT/CT
por: Wang, Feng, et al.
Publicado: (2021)

Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation
por: Jeon, Eon Ju, et al.
Publicado: (2014)

Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer
por: Biondi, Bernadette, et al.
Publicado: (2009)

Radioactive Iodine Remnant Ablation: The Beta-knife Completion Thyroidectomy
por: Gulec, Seza, et al.
Publicado: (2017)

The Temporal Impact of Prosthesis Implantation and Semi‐Quantitative Criteria on the Diagnostic Efficacy of Triple‐Phase Bone Scanning for Periprosthetic Joint Infection
por: Zhang, Feiyang, et al.
Publicado: (2022)

Measurement of the ratio sigma(nu$_{mu}$e --> nu$_{mu}$e)/sigma(n$\overline{u}$sub(mu)e --> n$\overline{u}$sub(mu)e)
por: Bergsma, F, et al.
Publicado: (1982)

A pre-ablative thyroid-stimulating hormone with 30–70 mIU/L achieves better response to initial radioiodine remnant ablation in differentiated thyroid carcinoma patients
por: Xiao, Juan, et al.
Publicado: (2021)

Thyroid Remnant Estimation by Diagnostic Dose (131) I Scintigraphy or (99m) T c O (4) (−) Scintigraphy after Thyroidectomy: A Comparison with Therapeutic Dose (131) I Imaging
por: Liu, Guanghui, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_oq2ul7njjpeq29dia3carpnljc